In collaboration with the European Commission CEBR delivers opinions on the role and status of European life sciences ecosystems and... View Article
Author Archives for Adeline Chauvigné
MEETING THE CHALLENGES FACING EUROPEAN HEALTHCARE ECOSYSTEMS
27 February 2026In collaboration with the European Commission CEBR delivers opinions on the role and status of European life sciences ecosystems and... View Article
CE4BIG: A EUROPEAN PROJECT COORDINATED BY THE SELECTED AND FUNDED CLUSTER
In 2019, the European project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector – was... View Article
CE4BIG: A EUROPEAN PROJECT COORDINATED BY THE SELECTED AND FUNDED CLUSTER
27 February 2026In 2019, the European project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector – was... View Article
RELIEF, A STRATEGIC PROJECT FOR GLIOCURE, SELECTED BY EUREKA !
Angers, 20th January 2020 – GlioCure SAS, a biotechnology company specialising in the field of neuro-oncology and a member of... View Article
RELIEF, A STRATEGIC PROJECT FOR GLIOCURE, SELECTED BY EUREKA !
27 February 2026Angers, 20th January 2020 – GlioCure SAS, a biotechnology company specialising in the field of neuro-oncology and a member of... View Article
FIGHTING CANCER WITH LASERS: A PROJECT DRIVEN BY PROFESSIONALS IN THE LANNION AREA APPROVED BY IMAGES ET RÉSEAUX AND ATLANPOLE BIOTHERAPIES
Seven researchers in Lannion are working on the UV4life project, approved by Images et Réseaux and Atlanpole Biotherapies and supported... View Article
FIGHTING CANCER WITH LASERS: A PROJECT DRIVEN BY PROFESSIONALS IN THE LANNION AREA APPROVED BY IMAGES ET RÉSEAUX AND ATLANPOLE BIOTHERAPIES
27 February 2026Seven researchers in Lannion are working on the UV4life project, approved by Images et Réseaux and Atlanpole Biotherapies and supported... View Article
Goliver Therapeutics, partnering the Paul Brousse Hospital in Villejuif
REGENERATIVE MEDECINE – AN ALTERNATIVE TO LIVER TRANSPLANTS In Nantes, on 9th December 2019, GoLiver Therapeutics, a start-up and member... View Article
Goliver Therapeutics, partnering the Paul Brousse Hospital in Villejuif
27 February 2026REGENERATIVE MEDECINE – AN ALTERNATIVE TO LIVER TRANSPLANTS In Nantes, on 9th December 2019, GoLiver Therapeutics, a start-up and member... View Article
DIRECTOSANTÉ aims to enhance the follow-up care of ambulatory patients in hospital environments
DIRECTOSANTÉ, AN E-HEALTH START-UP AND MEMBER OF THE ATLANPOLE BIOTHERAPIES COMPETITIVE CLUSTER, HAS SUCCESSFULLY COMPLETED ITS SECOND FUND-RAISING INITIATIVE AMOUNTING... View Article
DIRECTOSANTÉ aims to enhance the follow-up care of ambulatory patients in hospital environments
27 February 2026DIRECTOSANTÉ, AN E-HEALTH START-UP AND MEMBER OF THE ATLANPOLE BIOTHERAPIES COMPETITIVE CLUSTER, HAS SUCCESSFULLY COMPLETED ITS SECOND FUND-RAISING INITIATIVE AMOUNTING... View Article
The Angers University Hospital (CHU), a driving force in research and innovation
LATE 2019 AND EARLY 2020 WERE MARKED BY STRONG INNOVATION AT THE ANGERS CHU. THE HOSPITAL ESTABLISHED SEVERAL PARTNERSHIPS AIMED... View Article
The Angers University Hospital (CHU), a driving force in research and innovation
27 February 2026LATE 2019 AND EARLY 2020 WERE MARKED BY STRONG INNOVATION AT THE ANGERS CHU. THE HOSPITAL ESTABLISHED SEVERAL PARTNERSHIPS AIMED... View Article
Atlanpole Biotherapies excellence and expertise recognized at European level
Already structured to conduct international efforts, the cluster is now expanding its missions focus towards its members. Atlanpole Biotherapies is... View Article
Atlanpole Biotherapies excellence and expertise recognized at European level
27 February 2026Already structured to conduct international efforts, the cluster is now expanding its missions focus towards its members. Atlanpole Biotherapies is... View Article
Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed
The Company also confirms its mid-term intention to list on Nasdaq to co-fund late stage development of its Lyme disease... View Article
Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed
27 February 2026The Company also confirms its mid-term intention to list on Nasdaq to co-fund late stage development of its Lyme disease... View Article
New member | Vigier Avocats
Making the practice of law an asset! Vigier Avocats is an independent business law with a solid expertise in the... View Article
New member | Vigier Avocats
27 February 2026Making the practice of law an asset! Vigier Avocats is an independent business law with a solid expertise in the... View Article